• OPEN AN ACCOUNT
Indian Indices
Nifty
24,968.40 -143.05
(-0.57%)
Sensex
81,757.73 -501.51
( -0.61%)
Bank Nifty
56,283.00 -545.80
( -0.96%)
Nifty IT
37,141.90 3.35
( 0.01%)
Global Indices
Nasdaq
44,515.72 239.93
(0.54%)
Dow Jones
6,318.70 34.00
(0.54%)
Hang Seng
39,788.57 -112.62
(-0.28%)
Nikkei 225
8,972.64 46.09
(0.52%)
Forex
USD-INR
85.91 0.01
(0.01%)
EUR-INR
99.83 -0.21
(-0.21%)
GBP-INR
115.15 -0.11
(-0.09%)
JPY-INR
0.58 0.00
(-0.14%)

EQUITY - MARKET SCREENER

Remus Pharmaceuticals Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
78788
INE0O5T01011
205.5515954
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
REMUS
54.05
1075.76
EPS(TTM)
Face Value()
Div & Yield %
16.89
10
0
 

polycab india ltd
Aditya Birla Money ends lower after Q1 PAT slumps 6% YoY to Rs 15 cr
Jul 14,2025
Profit before tax (PBT) fell 7.89% YoY to Rs 20.56 crore in Q1 June 2025.

Total expenses dropped 5.22% to Rs 92.32 crore in Q1 FY26 compared with Rs 97.40 crore in Q1 FY25. Finance costs stood at Rs 31.59 crore (up 7.78% YoY), fees & commission expenses was at Rs 17.35 crore (down 28.86% YoY), employee benefit expenses stood at Rs 27.89 crore (up 3.03%) during the period under review.

Revenue from broking business stood at Rs 81.32 crore in Q1 FY26, down 18.59% compared with Rs 99.89 crore in Q1 FY25. Revenue from wholesale debt market jumped 63.07% YoY to Rs 30.64crore in Q1 FY26.

Revenue from interest jumped 9.49% YoY to Rs 55.37 crore while revenue from fees and commission fell 24.85% to Rs 44.21 crore in Q1 FY26 over Q1 FY25.

Aditya Birla Money (ABML) is a subsidiary of Aditya Birla Capital. The company is a stock broking and capital market products distributor, offering equity and derivative trading through NSE and BSE and currency derivatives on MCX-SX and commodities trading through MCX and NCDEX.